Skip to main
  1. Stocks
  2. Billiontoone Inc
  3. Forecast
BLLN

Billiontoone Inc (BLLN) Stock Forecast & Price Target

Billiontoone Inc (BLLN) Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

BillionToOne is compelling because its Q3 showed durable fundamental momentum, with revenue of $123M rising 47% Y/Y, a 6% top-line beat, 71% gross margin, and $23M of adjusted EBITDA, while cash remained strong at $562M. Its bullish case is reinforced by reimbursement de-risking and commercial scale, as payor coverage now totals about 300M lives, Q3 oncology revenue grew 96% Y/Y, and the company raised its 2026 revenue guide to $460M-$470M. In addition, the validation of Northstar Response against a market-leading MRD assay, the planned December 15, 2026 launch of Northstar Clear, and continued expansion in UNITY and oncology support a long runway for share gains and operating leverage.

Bears say

BillionToOne is facing a difficult fundamental setup because it operates in highly competitive prenatal and oncology diagnostics markets while relying on proprietary QCT technology that may be harder to defend amid litigation risk and intense rivals like Natera, Guardant Health, LabCorp, and Quest. Its business is also heavily exposed to reimbursement and billing execution, so delays in claims or failures to secure Medicare and Medicaid payment could directly pressure revenue from molecular tests that drive essentially all of its growth. Although 2026 revenue is modeled at $456M and 2028 at $780M, rising operating expenses of $293M and $438M, along with softer ASPs and margin pressure after Q2'26 gross margin fell to 70%, suggest scaling remains costly and execution-sensitive.

Billiontoone Inc (BLLN) has been analyzed by 8 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Billiontoone Inc and is not a guaranteed prediction by Public.com or investment advice.

Billiontoone Inc (BLLN) Analyst Forecast & Price Prediction

Get the latest Billiontoone Inc (BLLN) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Billiontoone Inc (BLLN)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Billiontoone Inc (BLLN) Forecast

Analysts have given Billiontoone Inc (BLLN) a Buy based on their latest research and market trends.

According to 8 analysts, Billiontoone Inc (BLLN) has a Buy consensus rating as of Nov 18, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $124.38, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $124.38, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Billiontoone Inc (BLLN)


Billiontoone Inc (BLLN) Analyst Forecast & Price Prediction

Get the latest Billiontoone Inc (BLLN) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Billiontoone Inc (BLLN)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover BLLN stock data and trends